Results 171 to 180 of about 181,956,994 (291)

Key breast cancer highlights from the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. [PDF]

Transl Breast Cancer Res
Venkataraman J, Mokbel K.
europepmc   +1 more source

What we learned in axillary management of breast cancer patients at the American society of clinical oncology (ASCO) 2020 virtual meeting? The EUBREAST point of view. [PDF]

EClinicalMedicine, 2021
Gasparri ML, Poortmans P, Banys-Paluchowski M, Bonci EA, Di Micco R, Condorelli R, Matrai Z, Dubsky P, Gentilini OD, Kuehn T.   +9 more
europepmc   +1 more source

Detection of multiple myeloma cells using multicolor flow cytometry

, 2004
40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LAWOS: 000223512402387…Amer Soc Clin ...
Kara, IO, Sahin, B
core  

From pathogen to “living drug factory” innovative strategies and clinical translation of bacteria as programmable intelligent vectors for cancer therapy

BMEMat, EarlyView.
Engineered bacteria serve as smart, living therapeutics that target tumors, deliver drugs, and remodel immunosuppressive microenvironments. This review highlights their potential to potentiate immunotherapy, radiotherapy, and chemotherapy, offering a promising paradigm for precise and synergistic cancer treatment. Abstract The dynamic interplay between
Haonan Shen, Weichen Zhang, Gaoli Niu, Li Wang, Ruiyan Li, Yueyue Fan, Feixue Lu, Lingling Xu, Xiaoyuan Ji, Yong Kang   +9 more
wiley   +1 more source

ASCO Global Guidelines: Methods and Opportunities

JCO Global Oncology
Zeba Aziz, Sarah Temin, Sarah Bachmann, Gilberto Lopes, Temidayo Fadelu   +4 more
doaj   +1 more source

Nanoagonist‐mediated spatiotemporal reprogramming of macrophage phenotypes to potentiate tumor immunotherapy

BMEMat, EarlyView.
This review systematically summarizes the major molecular mechanisms governing TAM polarization and their coordinated interactions. It further highlights recent advances in nanoagonist‐based strategies that intervene in these pathways to reprogram TAMs, critically discussing their therapeutic potential, current limitations, and translational prospects.
Siqi Fang, Fengfeng Xiao, Ruie Chen, Cuixia Lu, Yi Ju, Mingqing Yuan, Yunlu Dai, Liewei Wen   +7 more
wiley   +1 more source

Dreaming Big: Providing American Society of Clinical Oncology Guideline Concordant Oncofertility Care for Adolescents and Young Adults. [PDF]

J Adolesc Young Adult Oncol
Desai SP, Rice WS, Lake P, Walker ER, Barnett M, Augusto B, Quinn GP, Vadaparampil ST.   +7 more
europepmc   +1 more source

Research Progress on V2CTx MXene‐Based Composites: Synthetic Strategies, Structure Design, and Multifunctional Applications

Carbon Energy, EarlyView.
This review systematically and comprehensively summarizes the latest research progress on V2CTx MXene. Focusing on the structural design strategies, particularly the construction of the V2CTx‐based hetero‐composite structure. Furthermore, widespread applications including electrochemical energy storage and conversion, as well as photocatalytic ...
Wenjun Zhu, Minghai Zhao, Min Fan, Jianmin Luo, Jian Tian, Xinhui Xia, Wenkui Zhang, Xinyong Tao, Yanxian Jin, Yang Xia   +9 more
wiley   +1 more source

Scientific advances in drug development and clinical trials for urothelial carcinoma: Highlights from the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium. [PDF]

Asian J Urol
Wu R, Li D, Feng D.
europepmc   +1 more source

Cancer Disparities and Health Equity: A Policy Statement From the American Society of Clinical Oncology. [PDF]

J Clin Oncol, 2020
Patel MI, Lopez AM, Blackstock W, Reeder-Hayes K, Moushey EA, Phillips J, Tap W.   +6 more
europepmc   +1 more source